Status:
UNKNOWN
Lynch Syndrome Can be Diagnosed Just From Somatic Mismatch Repair Mutation
Lead Sponsor:
RWJ Barnabas Health at Jersey City Medical Center
Conditions:
Cancer Gene Mutation
Lynch Syndrome
Eligibility:
FEMALE
Brief Summary
The objective of the study is the provide proof of high correlation between somatic and germline mismatch repair instability. This correlation is specifically researched in an area where patients have...
Eligibility Criteria
Inclusion
- Underserved areas. Diagnosis of endometrial endometrioid carcinoma. Low socioeconomic status. Positive mismatch repair staining. All races. All ages. All cancer grades. All cancer stages .
Exclusion
- Diagnosis of type 2 endometrial carcinoma. Cancer diagnosis other than Endometrial. No mismatch repair genes mutation. High socioeconomic status.
Key Trial Info
Start Date :
December 21 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04516083
Start Date
December 21 2019
End Date
June 30 2021
Last Update
August 18 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jersey city medical center
Jersey City, New Jersey, United States, 07302